HealthLeaders’ Post

Exciting Update from CodeX! We’re thrilled to share that the Molecular Tumor Board (led by Bob Dolin)  and Pathogen Genomics (led by Emily Bordeleau) use cases are officially moving into the Planning stage of the CodeX Use Case Methodology. These use cases mark an important step in advancing interoperable standards to improve cancer care, precision medicine, and genomic data sharing across healthcare. Interested in getting involved? Reach out to us at 📩 pmo@hl7codex.org  — we’d love to hear from you! Elimu Informatics Simon Fraser University McMaster University #HL7 #FHIR #Interoperability #Genomics #Oncology #CodeX

What if fighting disease was as simple as flipping a switch? Yubin Zhou, PhD, professor in the Department of Translational Medical Sciences, has developed PhoBITs—compact, light-activated genetic switches that let scientists turn disease pathways on and off with precision. This innovation could open new doors for cancer treatment, immune regulation and targeted therapies with fewer side effects. Read more: https://ow.ly/fZsK50X7Qvq #AdvancingMedicine #AggieResearch #AggieDocs

Our new review paper is published! The paper is titled “DNA methylation and machine learning: challenges and perspectives toward enhanced clinical diagnostics.” It covers how recent progress in machine learning helps analyze DNA methylation data for better clinical diagnostics in cancer, cardiovascular, neurodevelopmental, and rare diseases. The review also outlines key methods and examples that connect research findings to medical applications. Full text available at: https://lnkd.in/duhjQX6Z I’d like to thank Dr. Amir Hossein Saeidian Dr. Erfan Aref-Eshghi, MD, PhD, DABMGG, FACMG, and my co-authors Arash B. Abadi and Amirreza Hooshmand for their valuable input and collaboration throughout this work. #DNAmethylation #MachineLearning #Bioinformatics #ClinicalDiagnostics

The October issue of JADA is out! Check out the cover article on dental screening programs for patients awaiting radiation therapy, and don’t miss investigations into the therapeutic potential of cannabidiol and intraoral scanners vs. desktop versions. #JADAJournals Aya Erquizi Noah Kalman Anshul Saxena, PhD Alessandro Villa Florida International University - Herbert Wertheim College of Medicine Miami Cancer Institute BAPTIST HEALTH SOUTH FLORIDA FOUNDATION INC

Castle is presenting new data at #ACG2025 demonstrating that its TissueCypher - Barrett's Esophagus test can provide risk insights beyond pathology alone, influencing clinical management to support earlier intervention for those at higher risk of progression to esophageal cancer and potentially reducing unnecessary procedures for those at lower risk. Details and poster highlights: https://hubs.la/Q03QgqFn0

🧬 The Nanobiosystems Group, led by Prof. Mariana M. , aims at developing miniaturized and highly sensitive biosensors for the diagnosis of diseases like cancer 🎗️ and infertility 🧫, as well as miniaturized and microrobotics tools 🤖 for the targeted delivery of drugs and cells 💊🧠 — enabling noninvasive medical operations 🩺✨ 🔗 https://lnkd.in/d8_SFGMQ #nanoGUNE #ActivityReport

Visualize Metabolism — As It Happens 🧬 At Metabolism & Cancer 2025, we're showcasing our novel hyperpolarized MRI agents that enable real-time visualization of cancer metabolism. Unlike traditional static measurements, POLARIS allows you to observe and quantify metabolic flux in living organisms. Why it matters: 🔬 Real-time metabolic flux in vivo: Unlock insights into cancer-related metabolic reprogramming. 🗺️ Spatial mapping of metabolic activity: Add a spatial dimension to your functional analysis. 📈 Non-invasive longitudinal studies: Track disease progression or therapeutic responses over time. 🏥 Clinical translation: Advance cancer diagnostics and enable more effective treatment monitoring. 👉Learn more: Visit us at our Booth or join our talk on October 8th at 3:20 PM. #Hyperpolarization #MRI #MedTech #MedicalImaging #Innovation

📣 Owlstone Medical wins £36m award from Advanced Research Projects Agency for Health (ARPA-H) to develop at-home cancer detection tests  𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲 ⤵️ ⚙️ Medical 📈 Grant 💰 £36m 🤝 Advanced Research Projects Agency for Health (ARPA-H) 🧑 Billy Boyle; David Ruiz Alonso 🌎 Cambridge, United Kingdom 🔗 𝗶𝗻 𝗰𝗼𝗺𝗺𝗲𝗻𝘁𝘀

⚕️What role can decentralized clinical trials play in increasing the geographic and demographic diversity of cancer patients participating in cutting-edge research, and what are the unique regulatory hurdles? #ClinicalTrials #HealthResearch #PatientAccess

🎯 Precision Prevention: Aspirin Isn’t One-Size-Fits-All Low-dose aspirin may reduce cancer risk in some older adults — but increase it in others, according to a new analysis of the ASPREE trial. The findings reveal major variability in how individuals respond to aspirin for cancer prevention, emphasizing the need for personalized approaches guided by genomics and aging biology. 💊 Evidence-based. Individualized. Data-driven. The future of prevention is precision medicine. #Aspirin #CancerPrevention #PrecisionMedicine #ClinicalPharmacy #Geroscience #Oncology #PublicHealth #PersonalizedCare